XML 22 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
 9 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net income (loss) $ 943,390 $ (1,127,608)
Adjustments to reconcile net loss to net cash used by operating activities:    
Stock based compensation 386,719 40,453
Restricted stock expense 39,100 117,300
Amortization of debt discounts 0 5,159
Issuance of stock / warrants for services 478,002 592,666
Amortization of debt issue costs 0 305,800
Depreciation and amortization 169,788 42,151
Inventory impairment 102,124 0
Loss on sale of property and equipment 69,311 4,000
Other-than-temporary impairment on marketable securities 0 175,000
Common stock issued as charitable contribution 0 17,000
Debt conversion expense 0 446,250
Marketable and Investment Other Securities 0 (1,562,000)
Non-cash consideration received for services provided (3,404,502) 0
Changes in operating assets and liabilities:    
Accounts receivable (45,402) (154,745)
Accounts receivable – related party (637,675) (114,000)
Other accounts receivable (1,204,003) 0
Other accounts receivable – related party 236,364 0
Note receivable (450,000) 0
Note receivable –- related party 114,802 0
Inventory 10,340 (109,661)
Prepaid expenses and other current assets (980,952) 67,434
Accounts payable and accrued expenses (324,785) (397,298)
Accounts payable and accrued expenses - related party (470,905) (39,725)
Interest Payable 0 184,889
Deferred Revenue 121,916 47,333
Deferred tax liability 6,000 42,250
Cash used by operating activities (4,840,368) (1,417,352)
Cash flows from investing activities:    
Purchase of investment other securities (300,000) 0
Purchase of intangible assets (360,000) 0
Purchase of property and equipment (2,465) (15,018)
Cash used by investing activities (662,465) (15,018)
Cash flows from financing activities:    
Proceeds from issuance of common stock 10,927,535 201,450
Proceeds from convertible note 0 2,125,000
Distributions paid to members’ of EE1 0 (59,551)
Distribution income 0 30,363
Debt issuance cost 0 (200,800)
Repayments of line of credit 0 (300,000)
Deferred issuance costs (285,086) 0
Cash provided by financing activities 10,642,449 1,796,462
Net increase (decrease) in cash 5,139,616 364,092
Cash and cash equivalents, beginning of period 284,246 34,258
Cash and cash equivalents, beginning of period 5,423,862 398,350
Cash Payments for:    
Interest expense 505 5,210
Non-cash financial activities:    
Warrants issued to IPO selling agent 171,600 0
Equity investment exchange to be issued in the future 160,000 0
Common stock issued to purchase membership interest – I’M1 0 971,667
Common stock issued to purchase membership interest – EE1 0 471,667
Common stock issued for services 0 592,666
Warrants issued with convertible notes 0 5,159
Noncontrolling interest transfer 0 856,547
Equity issued to purchase membership interest in subsidiary 0 242,000
Strike price adjustment on placement agent warrants 0 31,505
Common stock issued for warrant exercise 0 85,950
Fixed asset write off 0 7,000
Common stock issued for conversion of Line of Credit 0 773,177
Common stock issued for conversion of promissory notes $ 0 $ 2,252,500